Liraglutide + PYY 3-36 Combination Therapy Mimics Effects of Roux-en-Y Bypass on Early NAFLD Whilst Lacking-Behind in Metabolic Improvements.
Valentin MetznerGloria HerzogTobias HeckelThorsten BischlerJulia HasingerChristoph OttoFassnacht MartinAndreas GeierFlorian SeyfriedUlrich DischingerPublished in: Journal of clinical medicine (2022)
partly mimics the positive effects of RYGB on weight reduction and on hepatic steatosis, while its effects on metabolic function lack behind RYGB.